Peter L. Hoang - Net Worth and Insider Trading

Peter L. Hoang Net Worth

The estimated net worth of Peter L. Hoang is at least $115,402 dollars as of 2024-06-08. Peter L. Hoang is the President and CEO of Marker Therapeutics Inc and owns about 33,257 shares of Marker Therapeutics Inc (MRKR) stock worth over $115,402. Details can be seen in Peter L. Hoang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter L. Hoang has not made any transactions after 2021-03-16 and currently still holds the listed stock(s).

Transaction Summary of Peter L. Hoang

To

Peter L. Hoang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter L. Hoang owns 2 companies in total, including Marker Therapeutics Inc (MRKR) , and Bellicum Pharmaceuticals Inc (BLCM) .

Click here to see the complete history of Peter L. Hoang’s form 4 insider trades.

Insider Ownership Summary of Peter L. Hoang

Ticker Comapny Transaction Date Type of Owner
MRKR Marker Therapeutics Inc 2021-03-16 director & CEO and President
BLCM Bellicum Pharmaceuticals Inc 2014-12-17 Sr. VP of Bus. Development

Peter L. Hoang Latest Holdings Summary

Peter L. Hoang currently owns a total of 1 stock. Peter L. Hoang owns 33,257 shares of Marker Therapeutics Inc (MRKR) as of March 16, 2021, with a value of $115,402.

Latest Holdings of Peter L. Hoang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRKR Marker Therapeutics Inc 2021-03-16 33,257 3.47 115,402

Holding Weightings of Peter L. Hoang


Peter L. Hoang Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter L. Hoang has made a total of 2 transactions in Marker Therapeutics Inc (MRKR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Marker Therapeutics Inc is the acquisition of 14,286 shares on March 16, 2021, which cost Peter L. Hoang around $250,000.

Insider Trading History of Peter L. Hoang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter L. Hoang Trading Performance

GuruFocus tracks the stock performance after each of Peter L. Hoang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter L. Hoang is 18.27%. GuruFocus also compares Peter L. Hoang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter L. Hoang within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter L. Hoang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter L. Hoang

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.22 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter L. Hoang Ownership Network

Ownership Network List of Peter L. Hoang

No Data

Ownership Network Relation of Peter L. Hoang

Insider Network Chart

Peter L. Hoang Owned Company Details

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Peter L. Hoang is the director & CEO and President of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Marker Therapeutics Inc Insider Transactions

No Available Data

Peter L. Hoang Mailing Address

Above is the net worth, insider trading, and ownership report for Peter L. Hoang. You might contact Peter L. Hoang via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.

Discussions on Peter L. Hoang

No discussions yet.